Bazedoxifene
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06401 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 16 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | heparin cofactor 2 deficiency | KG + DL |
| 2 | antithrombin deficiency type 2 | KG + DL |
| 3 | Worth syndrome | KG + DL |
| 4 | amenorrhea (disease) | KG + DL |
| 5 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 6 | pregnancy associated osteoporosis | KG + DL |
| 7 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 8 | thrombophilia | KG + DL |
| 9 | primary release disorder of platelets | KG + DL |
| 10 | pseudo-von Willebrand disease | KG + DL |
| 11 | succinyl-CoA:3-ketoacid CoA transferase deficiency | KG + DL |
| 12 | severe nonproliferative diabetic retinopathy | KG + DL |
| 13 | acne (disease) | KG + DL |
| 14 | Glanzmann thrombasthenia | KG + DL |
| 15 | drug-induced osteoporosis | KG + DL |
| 16 | duodenal ulcer (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.